Total medical devices industry cross border deals worth $3bn were announced globally for April 2022, with the $1.2bn private equity deal with Natus Medical being the sector’s biggest investment, according to GlobalData’s deals database.
Go deeper with GlobalData
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked an increase of 114.3% over the previous month of $1.4bn and a drop of 57.1% when compared with the last 12-month average of $7bn.
In terms of number of cross border deals, the sector saw a drop of 32.79% with 41 deals in April 2022 when compared to the last 12-month average of 61 deals.
In value terms, North America led the activity with cross border deals worth $1.9bn in April 2022.
medical devices industry cross border deals in April 2022: Top deals
The top five cross border deals accounted for 77.9% of the overall value during April 2022.
The combined value of the top five cross border deals stood at $2.33bn, against the overall value of $3bn recorded for the month.
The top five medical devices industry cross border deals of April 2022 tracked by GlobalData were:
1) ArchiMed $1.2bn private equity deal with Natus Medical
2) The $541.63m acquisition of Phenox by Wallaby Medical
3) CVS Health,Export Development Bank of Iran,General Atlantic,Mass Mutual Ventures,Openspace Ventures,Sequoia Capital and SoftBank Vision Fund II $300m venture financing deal with Biofourmis
4) The $150m venture financing of BostonGene by Impact Investment Partners,Japan Industrial Partners and NEC
5) Integer $141.73m acquisition deal with Aran Biomedical
